CoChat

Inhibitors of TonB Function Identified by a High-Throughput Screen for Inhibitors of Iron Acquisition in Uropathogenic Escherichia coli CFT073

Open access
Yep, Alejandra, McQuade, Thomas, Kirchhoff, Paul, Larsen, Martha, Mobley, Harry L. T. · 2014 · mBio
Cited by 49

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

The urinary tract is one of the most common sites of infection in humans, and uropathogenic Escherichia coli (UPEC) is the main causative agent of urinary tract infections. Bacteria colonizing the urinary tract face extremely low iron availability. To counteract this, UPEC expresses a wide variety of iron acquisition systems. To exploit iron acquisition in UPEC as a global target for small-molecule inhibition, we developed and carried out a whole-cell growth-based high throughput screen of 149,243 compounds. Our primary assay was carried out under iron-limiting conditions. Hits in the primary screen were assayed using two counterscreens that ruled out iron chelators and compounds that inhibit growth by means other than inhibition of iron acquisition. We determined dose-response curves under two different iron conditions and purchased fresh compounds for selected hits. After retesting dose-response relationships, we identified 16 compounds that arrest growth of UPEC only under iron-limiting conditions. All compounds are bacteriostatic and do not inhibit proton motive force. A loss-of-target strategy was employed to identify the cellular target of these inhibitors. Two compounds lost inhibitory activity against a strain lacking TonB and were shown to inhibit irreversible adsorption of a TonB-dependent bacteriophage. Our results validate iron acquisition as a target for antibacterial strategies against UPEC and identify TonB as one of the cellular targets. IMPORTANCE Half of women will suffer at least one episode of urinary tract infection (UTI) during their lifetime. The current treatment for UTI involves antibiotic therapy. Resistance to currently used antibiotics has steadily increased over the last decade, generating a pressing need for the development of new therapeutic agents. Since iron is essential for colonization and scarce in the urinary tract, targeting iron acquisition would seem to be an attractive strategy. However, the multiplicity and redundancy of iron acquisition systems in uropathogenic Escherichia coli (UPEC) make it difficult to pinpoint a specific cellular target. Here, we identified 16 iron acquisition inhibitors through a whole-cell high-throughput screen, validating iron acquisition as a target for antibacterial strategies against UPEC. We also identified the cellular target of two of the inhibitors as the TonB system.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/mbio.01089-13

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 31

  1. 10.1128/AAC.06060-11 · DOI · Paper page
  2. 10.1016/j.ijantimicag.2009.04.012 · DOI · Paper page
  3. 10.1007/s00018-009-0051-1 · DOI · Paper page
  4. 10.1084/jem.130.3.643 · DOI · Paper page
  5. 10.1111/j.1365-2958.2008.06509.x · DOI · Paper page
  6. 10.1016/j.sbi.2005.07.001 · DOI
  7. 10.1046/j.1365-2958.2003.03579.x · DOI · Paper page
  8. 10.3389/fmicb.2011.00206 · DOI
  9. 10.1046/j.1365-2958.2001.02673.x · DOI · Paper page
  10. 10.1111/j.1365-2958.1994.tb01021.x · DOI · Paper page
  11. 10.1016/j.jmb.2004.11.026 · DOI
  12. 10.1529/biophysj.107.104158 · DOI
  13. 10.1074/jbc.M607611200 · DOI · Paper page
  14. 10.1021/bi900722p · DOI
  15. 10.1111/j.1574-6968.1988.tb02490.x · DOI
  16. 10.1517/17460441.2012.708335 · DOI · Paper page
  17. 10.1128/IAI.69.10.6179-6185.2001 · DOI · Paper page
  18. RouthMD ZaluckiY SuCC ZhangQ ShaferWM YuEW . 2011. Efflux pumps of the resistance-nodulation-division family: a perspective of their structure function and regulation in gram-negative bacteria. Adv. Enzymol. Relat. Areas Mol. Biol. 77:109–146. doi:10.1002/9780470920541.ch3. · DOI
  19. 10.1016/0003-2697(87)90612-9 · DOI · Paper page
  20. LitwinMS SaigalCS . 2007. Urologic diseases in America. NIH Publication 07-5512:3-7. NIH, Bethesda, MD.
  21. 10.1371/journal.ppat.1001187 · DOI · Paper page
  22. 10.1128/IAI.72.11.6373-6381.2004 · DOI · Paper page
  23. 10.1128/JB.01121-12 · DOI · Paper page
  24. 10.1099/mic.0.28682-0 · DOI · Paper page
  25. 10.1111/j.1365-2958.2011.07570.x · DOI · Paper page
  26. 10.1042/BJ20121771 · DOI · Paper page
  27. 10.1021/jm301819k · DOI
  28. WalshC . 2003. Antibiotics: actions origins resistance. ASM Press Washington DC. · DOI · Paper page
  29. 10.1128/iai.58.5.1281-1289.1990 · DOI · Paper page
  30. 10.1073/pnas.120163297 · DOI · Paper page
  31. 10.1177/108705719900400206 · DOI · Paper page

Cited by

See all 49

Metadata

Authors
Yep, A., McQuade, T., Kirchhoff, P., Larsen, M., & Mobley, H. L. T.
Venue
mBio
Published
2014-05
Volume
5
Issue
2
Pages
e01089-13
ISSN
  • 2150-7511 (ISSN-L)
  • 2161-2129
OpenAlex
W2159814816
Cited by
49
References
8
FWCI
4.27
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.